According to the AAN Practice Guideline Update: Vaccine-preventable Infections and Immunization in Multiple Sclerosis, how long before initiating immunosuppressive or immunomodulating therapy should practitioners vaccinate their patients with multiple sclerosis?
According to the AAN Practice Guideline Update: Vaccine-preventable Infections and Immunization in Multiple Sclerosis, how long before initiating immunosuppressive or immunomodulating (ISIM) therapy should practitioners vaccinate their patients with multiple sclerosis?
Better luck next time
For more information and to read the full guidelines, visit the American Academy of Neurology.
For more multiple sclerosis content, visit the Resource Center.
Nice job!